Parameswaran Hari
Seminars
Wednesday 12th November 2025
OBX-115 Engineered TIL with Regulatable Membrane- Bound IL15: Translational Data from Patients with Advanced Melanoma
12:00 pm
- OBX-115 is a highly differentiated TIL cell therapy with optimized characteristics for response and persistence
- This data confirms successful platform validation, supporting the proposed OBX-115 mechanism of action
- ACZ dose-driven regulatable mbIL15 expression on OBX-115 enables elimination of IL2 from the regimen and the potential for a safer, more effective TIL cell therapy
